Science ❯ Medical Research ❯ Clinical Trials

Drug Efficacy

Neurological Disorders Health Outcomes Long-acting Treatments GLP-1 Receptor Agonists Cardiovascular Disease Research GLP-1 Injections Neuroscience Alzheimer's Research GLP-1 Research HIV Research Preventive Medicine Weight Loss Treatments Side Effects of Medications Immunology Safety Assessments Weight Loss Mechanisms HIV Treatment Innovations Public Health

Novo’s New GLP‑1 Pill Tests Lilly’s Lead as Investors Eye Pfizer’s Cheaper Shares

Lilly’s premium price meets a new oral challenger in the GLP‑1 race.

Pfizer to Buy Metsera in Up to $7.3 Billion Obesity Bet

Novartis Licenses Arrowhead’s RNAi Parkinson’s Drug in Deal Worth Up to $2.2 Billion

EU Regulator Recommends AstraZeneca’s Low-Carbon COPD Inhaler